Charles Schwab Investment Management Inc Hookipa Pharma Inc. Transaction History

Charles Schwab Investment Management Inc

  • $429 Billion
  • Q1 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Hookipa Pharma Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 36,285 shares of HOOK stock, worth $21,408. This represents 0.0% of its overall portfolio holdings.

Number of Shares
36,285
Previous 36,285 -0.0%
Holding current value
$21,408
Previous $29,000 13.79%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$1.27 - $1.87 $46,081 - $67,852
36,285 New
36,285 $49,000
Q2 2022

Aug 15, 2022
SELL
$1.33 - $2.31 $54,123 - $94,003
-40,694 Closed
0 $0
Q1 2022

May 13, 2022
SELL
$1.26 - $2.52 $8,820 - $17,640
-7,000 Reduced 14.68%
40,694 $93,000
Q2 2021

Aug 16, 2021
BUY
$9.16 - $19.51 $91,224 - $194,300
9,959 Added 26.39%
47,694 $437,000
Q1 2021

May 17, 2021
BUY
$10.64 - $14.7 $54,732 - $75,616
5,144 Added 15.78%
37,735 $508,000
Q3 2020

Nov 13, 2020
BUY
$8.59 - $11.89 $49,822 - $68,962
5,800 Added 21.65%
32,591 $309,000
Q2 2020

Aug 14, 2020
BUY
$7.23 - $12.1 $39,548 - $66,187
5,470 Added 25.66%
26,791 $312,000
Q4 2019

Feb 07, 2020
BUY
$6.51 - $12.23 $138,799 - $260,755
21,321 New
21,321 $261,000

Others Institutions Holding HOOK

# of Institutions
50
Shares Held
32.5M
Call Options Held
105K
Put Options Held
43.6K
View Full List

About HOOKIPA Pharma Inc.

HOOK Quotes by TradingView
  • Ticker HOOK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,654,500
  • Market Cap $30.5M
  • Description
  • HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transpl...
More about HOOK
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email